We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
-2.12%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$284B
AUM Growth
-$3.39B
Cap. Flow
-$3.28B
Cap. Flow %
-1.16%
Top 10 Hldgs %
25.31%
Holding
3,279
New
74
Increased
1,024
Reduced
1,721
Closed
74

Top Buys

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$580M
2
INTC icon
Intel
INTC
+$382M
3
ZTS icon
Zoetis
ZTS
+$256M
4
PM icon
Philip Morris
PM
+$225M
5
HON icon
Honeywell
HON
+$208M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$562M
2
RTX icon
RTX Corp
RTX
+$425M
3
AAPL icon
Apple
AAPL
+$365M
4
UNP icon
Union Pacific
UNP
+$312M
5
MSFT icon
Microsoft
MSFT
+$254M

Sector Composition

Rank Sector Weight
1 Technology 26.53%
2 Healthcare 12.08%
3 Financials 11.17%
4 Consumer Discretionary 10.62%
5 Industrials 8.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMEA icon
2726
Biomea Fusion
BMEA
$91.3M
$616K ﹤0.01%
44,787
-10,288
-19% -$186K
NSTG
2727
DELISTED
NanoString Technologies, Inc.
NSTG
$614K ﹤0.01%
356,742
+46,415
+15% +$141K
SVRA icon
2728
Savara
SVRA
$1.19B
$613K ﹤0.01%
162,212
+17,877
+12% +$63.7K
PETS icon
2729
PetMed Express
PETS
$42.3M
$611K ﹤0.01%
59,567
-107
-0.2% -$1.32K
FATE icon
2730
Fate Therapeutics
FATE
$326M
$608K ﹤0.01%
286,950
-1,771
-0.6% -$5.87K
LCTX icon
2731
Lineage Cell Therapeutics
LCTX
$278M
$608K ﹤0.01%
515,445
KPTI icon
2732
Karyopharm Therapeutics
KPTI
$48M
$606K ﹤0.01%
30,160
-742
-2% -$16.7K
LE icon
2733
Lands' End
LE
$403M
$603K ﹤0.01%
80,696
HBIO icon
2734
Harvard Bioscience
HBIO
$29.2M
$602K ﹤0.01%
14,000
NAUT icon
2735
Nautilus Biotechnolgy
NAUT
$115M
$601K ﹤0.01%
190,312
-1,609
-0.8% -$5.24K
EP icon
2736
Empire Petroleum
EP
$111M
$599K ﹤0.01%
62,162
TERN
2737
DELISTED
Terns Pharmaceuticals
TERN
$597K ﹤0.01%
118,680
-57,458
-33% -$365K
ABUS icon
2738
Arbutus Biopharma
ABUS
$915M
$593K ﹤0.01%
292,022
-1,701
-0.6% -$3.57K
ATNM icon
2739
Actinium Pharmaceuticals
ATNM
$25M
$588K ﹤0.01%
99,346
GRTS
2740
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$587K ﹤0.01%
341,449
KALV
2741
DELISTED
KalVista Pharmaceuticals
KALV
$587K ﹤0.01%
60,952
-831
-1% -$8.49K
EVCM icon
2742
EverCommerce
EVCM
$1.93B
$587K ﹤0.01%
58,480
-706
-1% -$7.58K
KRO icon
2743
KRONOS Worldwide
KRO
$989M
$587K ﹤0.01%
75,684
-1,291
-2% -$11.2K
MG icon
2744
Mistras Group
MG
$512M
$586K ﹤0.01%
107,537
OLPX
2745
DELISTED
Olaplex Holdings
OLPX
$585K ﹤0.01%
300,147
-4,957
-2% -$14.9K
MCBC
2746
DELISTED
Macatawa Bank Corp
MCBC
$584K ﹤0.01%
65,194
-848
-1% -$7.92K
VUZI icon
2747
Vuzix
VUZI
$224M
$582K ﹤0.01%
160,290
-279
-0.2% -$1.24K
NDLS icon
2748
Noodles & Co
NDLS
$107M
$580K ﹤0.01%
29,493
-682
-2% -$16.4K
CRMD icon
2749
CorMedix
CRMD
$584M
$580K ﹤0.01%
156,825
-40,210
-20% -$160K
INZY
2750
DELISTED
Inozyme Pharma
INZY
$579K ﹤0.01%
137,749

Similar funds

Nuveen's Q3 2023 Portfolio in Review

As of Q3 2023, Nuveen held 3,279 positions worth $284B, down 1.2% from $287B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 4.5%. Nuveen opened 74 new positions and exited 74, leaving the 3,279-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.

  • Nuveen's largest Q3 2023 buy was Primo Water Corporation: 4,446,437 shares worth $61.4M.
  • Nuveen added most to Kenvue in Q3 2023, an estimated $580M increase.
  • Nuveen's biggest Q3 2023 reduction was PepsiCo, cutting an estimated $562M.
  • Nuveen fully exited Life Storage, Inc. in Q3 2023, selling an estimated $77.3M.
  • Nuveen's ten largest holdings make up 25% of its $284B portfolio in Q3 2023.
  • Nuveen opened 74 new positions and closed 74 in Q3 2023.
  • Nuveen's portfolio value fell 1.2% quarter-over-quarter to $284B.

Based on Nuveen's 13F filing for Q3 2023, filed 14 Nov 2023.